Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren

Showing results (231-240 of 1,117) with videos related to

Pageof 112
Sort By:
The Journal of Biological Chemistry|June 10, 1972
Affinity labeling of steroid binding sites. Synthesis of 16 -bromoacetoxyprogesterone and its use for affinity labeling of 20 -hydroxysteroid dehydrogenaseF Sweet, F Arias, J C Warren
The Journal of Antimicrobial Chemotherapy|February 1, 1982
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
The Journal of Biological Chemistry|March 10, 1982
Spatial relationship of steroid and cofactor at the active site of human placental estradiol 17 beta-dehydrogenaseC C Chin, J Pineda, J C Warren
Nature Materials|January 24, 2007
Nanoparticle-tuned assembly and disassembly of mesostructured silica hybridsScott C Warren, Francis J Disalvo, Ulrich Wiesner
Nature Clinical Practice. Neurology|August 26, 2006
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's diseaseC Warren Olanow, José A Obeso, Fabrizio Stocchi
Neurology|May 24, 2006
Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's diseaseBiplob Dass, C Warren Olanow, Jeffrey H Kordower
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Milestones in movement disorders clinical trials: advances and landmark studiesC Warren Olanow, Kathryn B Wunderle, Karl Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin YahrAndrew J Lees, Eduardo Tolosa, C Warren Olanow
The Journal of Antimicrobial Chemotherapy|January 1, 1983
Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 30, 1996
The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasmC R Wilkinson, L M Bower, C Warren
Pageof 112

Showing results (231-240 of 1,117) with videos related to

Sort By:
Pageof 112
The Journal of Biological Chemistry|June 10, 1972
Affinity labeling of steroid binding sites. Synthesis of 16 -bromoacetoxyprogesterone and its use for affinity labeling of 20 -hydroxysteroid dehydrogenaseF Sweet, F Arias, J C Warren
The Journal of Antimicrobial Chemotherapy|February 1, 1982
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
The Journal of Biological Chemistry|March 10, 1982
Spatial relationship of steroid and cofactor at the active site of human placental estradiol 17 beta-dehydrogenaseC C Chin, J Pineda, J C Warren
Nature Materials|January 24, 2007
Nanoparticle-tuned assembly and disassembly of mesostructured silica hybridsScott C Warren, Francis J Disalvo, Ulrich Wiesner
Nature Clinical Practice. Neurology|August 26, 2006
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's diseaseC Warren Olanow, José A Obeso, Fabrizio Stocchi
Neurology|May 24, 2006
Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's diseaseBiplob Dass, C Warren Olanow, Jeffrey H Kordower
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Milestones in movement disorders clinical trials: advances and landmark studiesC Warren Olanow, Kathryn B Wunderle, Karl Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin YahrAndrew J Lees, Eduardo Tolosa, C Warren Olanow
The Journal of Antimicrobial Chemotherapy|January 1, 1983
Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 30, 1996
The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasmC R Wilkinson, L M Bower, C Warren
Pageof 112